[Renal toxicity of intraperitoneal cisplatin: a case report].
The new technique of treating ovarian tumours by giving cisplatin intra-peritoneally does have its risks. This case history reports the case of a patient who was treated in this way and following the treatment had renal failure severe enough to require dialyses. The methods of administering cisplatin through this route have not yet been worked out completely. It is absolutely to over hydrate the patient beforehand.
Thomas
C
C
Département d'Anesthésie-Réanimation, CHU Morvan, Brest.
Quinio
P
P
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D001706:Biopsy; D002945:Cisplatin / Q000009:adverse effects*; D003131:Combined Modality Therapy; D005260:Female; D005355:Fibrosis; D006440:Hemofiltration; D006801:Humans; D007274:Injections, Intraperitoneal; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D010385:Pelvic Exenteration
D002945:Cisplatin
Toxicité rénale du cisplatine intrapéritonéal: une observation.